Quadrature Capital’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-24,659
Closed -$123K 1201
2025
Q2
$123K Buy
24,659
+14,231
+136% +$61.8K ﹤0.01% 875
2025
Q1
$46K Buy
+10,428
New +$48.9K ﹤0.01% 981
2024
Q3
Sell
-79,558
Closed -$621K 1119
2024
Q2
$621K Buy
+79,558
New +$589K 0.01% 596
2023
Q2
Sell
-47,159
Closed -$295K 1057
2023
Q1
$295K Sell
47,159
-5,952
-11% -$33.2K 0.01% 677
2022
Q4
$247K Buy
53,111
+40,650
+326% +$200K 0.01% 673
2022
Q3
$58K Buy
+12,461
New +$78.6K ﹤0.01% 803

Other funds holding GDRX

Quadrature Capital's GDRX Position: Q3 2025 in Review

Quadrature Capital sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 24,659 shares — an estimated $123K sold.

Quadrature Capital first reported a position in GDRX in Q3 2022 and held it in 6 quarters. The position peaked at $621K in Q2 2024. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

  • Quadrature Capital reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
  • Quadrature Capital sold 24,659 GoodRx Holdings shares in Q3 2025, an estimated $123K.
  • Quadrature Capital first reported a position in GoodRx Holdings in Q3 2022 and held it in 6 quarters.
  • Quadrature Capital's GoodRx Holdings position peaked at $621K in Q2 2024.
  • 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on Quadrature Capital's 13F filing for Q3 2025, filed 13 Nov 2025.